Literature DB >> 10938464

Modification of creatine kinase by S-nitrosothiols: S-nitrosation vs. S-thiolation.

E A Konorev1, B Kalyanaraman, N Hogg.   

Abstract

Creatine kinase is reversibly inhibited by incubation with S-nitrosothiols. Loss of enzyme activity is associated with the depletion of 5,5'-dithiobis (2-nitrobenzoic acid)-accessible thiol groups, and is not due to nitric oxide release from RSNO. Full enzymatic activity and protein thiol content are restored by incubation of the S-nitrosothiol-modified protein with glutathione. S-nitroso-N-acetylpenicillamine, which contains a more sterically hindered S-nitroso group than S-nitrosoglutathione, predominantly modifies the protein thiol to an S-nitrosothiol via a transnitrosation reaction. In contrast, S-nitrosoglutathione modifies creatine kinase predominantly by S-thiolation. Both S-nitroso-N-acetylpenicillamine and S-nitrosoglutathione modify bovine serum albumin to an S-nitroso derivative. This indicates that S-thiolation and S-nitrosation are both relevant reactions for S-nitrosothiols, and the relative importance of these reactions in biological systems depends on both the environment of the protein thiol and on the chemical nature of the S-nitrosothiol.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10938464     DOI: 10.1016/s0891-5849(00)00281-1

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  19 in total

Review 1.  S-Nitrosothiol biology and therapeutic potential in metabolic disease.

Authors:  Christopher G Kevil; Rakesh P Patel
Journal:  Curr Opin Investig Drugs       Date:  2010-10

Review 2.  An evolving understanding of the S-glutathionylation cycle in pathways of redox regulation.

Authors:  Jie Zhang; Zhi-Wei Ye; Shweta Singh; Danyelle M Townsend; Kenneth D Tew
Journal:  Free Radic Biol Med       Date:  2018-03-23       Impact factor: 7.376

Review 3.  S-nitrosoglutathione.

Authors:  Katarzyna A Broniowska; Anne R Diers; Neil Hogg
Journal:  Biochim Biophys Acta       Date:  2013-02-14

4.  Direct activation of human phospholipase C by its well known inhibitor u73122.

Authors:  Ryan R Klein; David M Bourdon; Chester L Costales; Craig D Wagner; Wendy L White; Jon D Williams; Stephanie N Hicks; John Sondek; Dhiren R Thakker
Journal:  J Biol Chem       Date:  2011-01-25       Impact factor: 5.157

5.  Mass spectrometry-based quantitative proteomics for dissecting multiplexed redox cysteine modifications in nitric oxide-protected cardiomyocyte under hypoxia.

Authors:  Kuan-Ting Pan; Yi-Yun Chen; Tsung-Hsien Pu; Yu-Shu Chao; Chun-Yi Yang; Ryan D Bomgarden; John C Rogers; Tzu-Ching Meng; Kay-Hooi Khoo
Journal:  Antioxid Redox Signal       Date:  2013-10-23       Impact factor: 8.401

Review 6.  The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer.

Authors:  Kenneth D Tew; Yefim Manevich; Christina Grek; Ying Xiong; Joachim Uys; Danyelle M Townsend
Journal:  Free Radic Biol Med       Date:  2011-04-22       Impact factor: 7.376

Review 7.  S-glutathionylation: from redox regulation of protein functions to human diseases.

Authors:  Daniela Giustarini; R Rossi; A Milzani; R Colombo; Isabella Dalle-Donne
Journal:  J Cell Mol Med       Date:  2004 Apr-Jun       Impact factor: 5.310

8.  Guanidinoacetate decreases antioxidant defenses and total protein sulfhydryl content in striatum of rats.

Authors:  Alexandra I Zugno; Francieli M Stefanello; Emilene B S Scherer; Cristiane Mattos; Carolina D Pederzolli; Vanessa M Andrade; Clovis M D Wannmacher; Moacir Wajner; Carlos S Dutra-Filho; Angela T S Wyse
Journal:  Neurochem Res       Date:  2008-03-15       Impact factor: 3.996

9.  Exposure of rat optic nerves to nitric oxide causes protein S-nitrosation and myelin decompaction.

Authors:  Oscar A Bizzozero; Gisela DeJesus; Tamara A Howard
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

10.  Identification of major S-nitrosylated proteins in murine experimental autoimmune encephalomyelitis.

Authors:  Oscar A Bizzozero; Jianzheng Zheng
Journal:  J Neurosci Res       Date:  2009-10       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.